CVE-2022-3071

Description

Use after free in Tab Strip in Google Chrome on Chrome OS, Lacros prior to 105.0.5195.52 allowed a remote attacker who convinced a user to engage in specific UI interactions to potentially exploit heap corruption via crafted UI interaction.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.63%
Vendor Advisory gentoo.org Vendor Advisory fedoraproject.org Vendor Advisory googleblog.com Vendor Advisory crbug.com
Affected: Google Chrome
Published at:
Updated at:

References

Link Tags
https://chromereleases.googleblog.com/2022/08/stable-channel-update-for-desktop_30.html release notes vendor advisory
https://crbug.com/1333995 permissions required vendor advisory
https://security.gentoo.org/glsa/202209-23 third party advisory vendor advisory
https://lists.fedoraproject.org/archives/list/package-announce%40lists.fedoraproject.org/message/T4NMJURTG5RO3TGD7ZMIQ6Z4ZZ3SAVYE/ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-3071?
CVE-2022-3071 has been scored as a high severity vulnerability.
How to fix CVE-2022-3071?
To fix CVE-2022-3071, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-3071 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-3071 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-3071?
CVE-2022-3071 affects Google Chrome.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.